Search research articles
Contact Us
Filters
Showing results (81-90 of 145) with videos related to
Page
of 15
Sort By:
Seminars in Nuclear Medicine
|
April 10, 2023
Is There a Role of Artificial Intelligence in Preclinical Imaging?
Alina Küper, Paul Blanc-Durand, Andrei Gafita, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection
|
September 6, 2022
Radiation dose aspects and establishment of diagnostic reference levels for<sup>90</sup>Y radioembolisation during angiographic procedure
Marcel Opitz, Sebastian Zensen, Johannes Maximilian Ludwig, et al.
Endocrine Connections
|
December 12, 2022
Predictive value of highly sensitive basal versus stimulated thyroglobulin measurement in long-term follow-up of thyroid cancer
Kim Magaly Pabst, Robert Seifert, Nader Hirmas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2022
Unspecific <sup>18</sup>F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
Robert Seifert, Tugce Telli, Marcel Opitz, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
September 19, 2024
Early treatment response assessment with [<sup>177</sup>Lu]PSMA whole-body-scintigraphy compared to interim PSMA-PET
David Ventura, Philipp Rassek, Philipp Schindler, et al.
Nuklearmedizin. Nuclear Medicine
|
July 22, 2020
Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma
Michael Müther, Wolfgang Roll, Benjamin Brokinkel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 1, 2023
Evaluation of thresholding methods for the quantification of [<sup>68</sup>Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy
Moon Kim, Robert Seifert, Jana Fragemann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 15, 2024
Using a novel PSMA-PET and PSA-based model to enhance the diagnostic accuracy for clinically significant prostate cancer and avoid unnecessary biopsy in men with PI-RADS ≤ 3 MRI
Yujia Li, Jian Li, Jinhui Yang, et al.
PET Clinics
|
November 21, 2025
Artificial Intelligence for Simplified Patient-centered Dosimetry in Radiopharmaceutical Therapies
Alejandro Lopez Montes, Fereshteh Yousefirizi, Yizhou Chen, et al.
EJNMMI Physics
|
June 12, 2026
Impact of scan duration and scatter correction on quantitative accuracy in Yttrium-90 PET/CT imaging using LAFOV and SAFOV systems: a phantom and clinical evaluation
Konstantinos G Zeimpekis, Magdalena Kulgawczuk, Carola Bregenzer, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 145) with videos related to
Sort By:
Page
of 15
Seminars in Nuclear Medicine
|
April 10, 2023
Is There a Role of Artificial Intelligence in Preclinical Imaging?
Alina Küper, Paul Blanc-Durand, Andrei Gafita, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection
|
September 6, 2022
Radiation dose aspects and establishment of diagnostic reference levels for<sup>90</sup>Y radioembolisation during angiographic procedure
Marcel Opitz, Sebastian Zensen, Johannes Maximilian Ludwig, et al.
Endocrine Connections
|
December 12, 2022
Predictive value of highly sensitive basal versus stimulated thyroglobulin measurement in long-term follow-up of thyroid cancer
Kim Magaly Pabst, Robert Seifert, Nader Hirmas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2022
Unspecific <sup>18</sup>F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
Robert Seifert, Tugce Telli, Marcel Opitz, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
September 19, 2024
Early treatment response assessment with [<sup>177</sup>Lu]PSMA whole-body-scintigraphy compared to interim PSMA-PET
David Ventura, Philipp Rassek, Philipp Schindler, et al.
Nuklearmedizin. Nuclear Medicine
|
July 22, 2020
Response assessment of somatostatin receptor targeted radioligand therapies for progressive intracranial meningioma
Michael Müther, Wolfgang Roll, Benjamin Brokinkel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 1, 2023
Evaluation of thresholding methods for the quantification of [<sup>68</sup>Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy
Moon Kim, Robert Seifert, Jana Fragemann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 15, 2024
Using a novel PSMA-PET and PSA-based model to enhance the diagnostic accuracy for clinically significant prostate cancer and avoid unnecessary biopsy in men with PI-RADS ≤ 3 MRI
Yujia Li, Jian Li, Jinhui Yang, et al.
PET Clinics
|
November 21, 2025
Artificial Intelligence for Simplified Patient-centered Dosimetry in Radiopharmaceutical Therapies
Alejandro Lopez Montes, Fereshteh Yousefirizi, Yizhou Chen, et al.
EJNMMI Physics
|
June 12, 2026
Impact of scan duration and scatter correction on quantitative accuracy in Yttrium-90 PET/CT imaging using LAFOV and SAFOV systems: a phantom and clinical evaluation
Konstantinos G Zeimpekis, Magdalena Kulgawczuk, Carola Bregenzer, et al.
Page
of 15